CAS |
No.545395-94-6 |
英文名称 |
AMG-9810 |
别名 |
(2E)-N-(2,3-二氢-1,4-苯并二噁英-6-基)-3-[4-(1,1-二甲基乙基)苯基]-2-丙酰胺 |
分子式 |
C21H23NO3 |
分子量 |
337.41 |
溶解性 |
Soluble in DMSO |
纯度 |
≥99% |
外观(性状) |
Light brown to brown Solid |
储存条件 |
Powder:-20℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year |
MDL |
MFCD00955103 |
SMILES |
CC(C)(C)C1=CC=C(C=C1)C=CC(=O)NC2=CC3=C(C=C2)OCCO3 |
InChIKey |
GZTFUVZVLYUPRG-IZZDOVSWSA-N |
InChI |
InChI=1S/C21H23NO3/c1-21(2,3)16-7-4-15(5-8-16)6-11-20(23)22-17-9-10-18-19(14-17)25-13-12-24-18/h4-11,14H,12-13H2,1-3H3,(H,22,23)/b11-6+ |
PubChem CID |
680502 |
靶点 |
TRPV1 |
通路 |
Membrane Transporter&Ion Channel;Neuronal Signaling |
背景说明 |
是选择性和竞争性的香草素受体1 (TRPV1) 拮抗剂。 |
生物活性 |
AMG9810 是一种 TRPV1 拮抗剂,对人类和大鼠 TRPV1 的 IC50 值分别为 24.5 和 85.6 nM。[1-2] |
IC50 |
human TRPV1: 24.5nM(IC50);rat TRPV1:85.6nM(IC50)[1] |
In Vitro |
AMG 9810 is a competitive antagonist of capsaicin activation(IC50 value for human TRPV1,24.5 +/- 15.7 nM; rat TRPV1,85.6 +/- 39.4 nM)and blocks all known modes of TRPV1 activation,including protons(IC50 value for rat TRPV1,294 +/- 192 nM; human TRPV1,92.7 +/- 72.8 nM),heat(IC50 value for rat TRPV1,21 +/- 17 nM; human TRPV1,15.8 +/- 10.8 nM),and endogenous ligands,such as anandamide,N-arachidonyl dopamine,and oleoyldopamine.[1] |
In Vivo |
AMG 9810 is effective at preventing capsaicin-induced eye wiping in a dose-dependent manner,and it reverses thermal and mechanical hyperalgesia in a model of inflammatory pain induced by intraplantar injection of complete Freund's adjuvant.[1] AMG9810,promotes mouse skin tumorigenesis mediated through EGFR/Akt/mTOR signaling.[2] |
数据来源文献 |
[1]. Gavva NR,et al. AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide],a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J Pharmacol Exp Ther. 2005 Apr;313(1):474-84. [2]. Li S,et al. TRPV1-antagonist AMG9810 promotes mouse skin tumorigenesis through EGFR/Akt signaling. Carcinogenesis. 2011 May;32(5):779-85. |
规格 |
1mg 5mg 10mg 25mg 50mg |
单位 |
瓶 |